MicroRNA-130a inhibits HCV replication by restoring the innate immune response

Journal of Viral Hepatitis

Volumn 21, Issue 2, 2014, Pages 121-128

  Li, S ^a   Duan, X ^a   Li, Y ^a   Liu, B ^a   McGilvray, I ^a,b   Chen, L ^a,b  

^a INSTITUTE OF BLOOD TRANSFUSION   (China)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

hepatitis C virus; innate immune response; interferon stimulated genes; microRNA 122; microRNA 130a

Indexed keywords

MICRORNA; MIRN130 MICRORNA, HUMAN;

ARTICLE; DOWN REGULATION; GENE EXPRESSION; HEPATITIS C VIRUS; IN VITRO GENE TRANSFER; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA REPLICATION; UPREGULATION; VIRUS INHIBITION; VIRUS REPLICATION; CELL LINE; HEPACIVIRUS; HUMAN; IMMUNOLOGY; LIVER CELL; METABOLISM; PHYSIOLOGY; VIROLOGY;

CELL LINE; HEPACIVIRUS; HEPATOCYTES; HUMANS; IMMUNITY, INNATE; MICRORNAS; VIRUS REPLICATION;

EID: 84891837132     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12131     Document Type: Article

References (27)

1. Murakami Y, Aly HH, Tajima A, et al,. Regulation of the hepatitis C virus genome replication by miR-199a. J Hepatol 2009; 50 (3): 453-460.
2. Georgel P, Schuster C, Zeisel MB, et al,. Virus-host interactions in hepatitis C virus infection: implications for molecular pathogenesis and antiviral strategies. Trends Mol Med 2010; 16 (6): 277-286.
3. Susser S, Vermehren J, Forestier N, et al,. Analysis of long-term persistence of resistance mutations within the hepatitis C virus NS3 protease after treatment with telaprevir or boceprevir. J Clin Virol 2011; 52 (4): 321-327.
4. Fonseca-Coronado S, Escobar-Gutierrez A, Ruiz-Tovar K, et al,. Specific detection of naturally occurring hepatitis C virus mutants with resistance to telaprevir and boceprevir (protease inhibitors) among treatment-naive infected individuals. J Clin Microbiol 2012; 50 (2): 281-287.
5. Sarrazin C, Kieffer TL, Bartels D, et al,. Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevir. Gastroenterology 2007; 132 (5): 1767-1777.
6. Kim VN,. MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol 2005; 6 (5): 376-385.
7. Yeung ML, Yasunaga J, Bennasser Y, et al,. Roles for microRNAs, miR-93 and miR-130b, and tumor protein 53-induced nuclear protein 1 tumor suppressor in cell growth dysregulation by human T-cell lymphotrophic virus 1. Cancer Res 2008; 68 (21): 8976-8985.
8. Hou YY, Cao WW, Li L, et al,. MicroRNA-519d targets MKi67 and suppresses cell growth in the hepatocellular carcinoma cell line QGY-7703. Cancer Lett 2011; 307 (2): 182-190.
9. Zhou C, Liu J, Li Y, et al,. microRNA-1274a, a modulator of sorafenib induced a disintegrin and metalloproteinase 9 (ADAM9) down-regulation in hepatocellular carcinoma. FEBS Lett 2011; 585 (12): 1828-1834.
10. Jopling CL, Yi M, Lancaster AM, et al,. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 2005; 309 (5740): 1577-1581.
11. Liu X, Wang T, Wakita T, et al,. Systematic identification of microRNA and messenger RNA profiles in hepatitis C virus-infected human hepatoma cells. Virology 2010; 398 (1): 57-67.
12. Peng X, Li Y, Walters KA, et al,. Computational identification of hepatitis C virus associated microRNA-mRNA regulatory modules in human livers. BMC Genomics 2009; 10: 373.
13. Steuerwald NM, Parsons JC, Bennett K, et al,. Parallel microRNA and mRNA expression profiling of (genotype 1b) human hepatoma cells expressing hepatitis C virus. Liver Int 2010; 30 (10): 1490-1504.
14. Meylan E, Curran J, Hofmann K, et al,. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 2005; 437 (7062): 1167-1172.
15. Arnaud N, Dabo S, Maillard P, et al,. Hepatitis C virus controls interferon production through PKR activation. PLoS ONE 2010; 5 (5): e10575.
16. Martensen PM, Justesen J,. Small ISGs coming forward. J Interferon Cytokine Res 2004; 24 (1): 1-19.
17. Jangra RK, Yi M, Lemon SM,. Regulation of hepatitis C virus translation and infectious virus production by the microRNA miR-122. J Virol 2010; 84 (13): 6615-6625.
18. Pedersen IM, Cheng G, Wieland S, et al,. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 2007; 449 (7164): 919-922.
19. Lecellier CH, Dunoyer P, Arar K, et al,. A cellular microRNA mediates antiviral defense in human cells. Science 2005; 308 (5721): 557-560.
20. Nathans R, Chu CY, Serquina AK, et al,. Cellular microRNA and P bodies modulate host-HIV-1 interactions. Mol Cell 2009; 34 (6): 696-709.
21. Asselah T, Bieche I, Sabbagh A, et al,. Gene expression and hepatitis C virus infection. Gut 2009; 58 (6): 846-858.
22. Blindenbacher A, Duong FH, Hunziker L, et al,. Expression of hepatitis c virus proteins inhibits interferon alpha signaling in the liver of transgenic mice. Gastroenterology 2003; 124 (5): 1465-1475.
23. O'Connell RM, Taganov KD, Boldin MP, et al,. MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A 2007; 104 (5): 1604-1609.
24. Jopling CL,. Targeting microRNA-122 to Treat Hepatitis C Virus Infection. Viruses 2010; 2 (7): 1382-1393.
25. Elmen J, Lindow M, Schutz S, et al,. LNA-mediated microRNA silencing in non-human primates. Nature 2008; 452 (7189): 896-899.
26. Stenvang J, Petri A, Lindow M, et al,. Inhibition of microRNA function by antimiR oligonucleotides. Silence 2012; 3 (1): 1.
27. Lanford RE, Hildebrandt-Eriksen ES, Petri A, et al,. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010; 327 (5962): 198-201.